The Expression Level of HIV-1 Vif Is Optimized by Nucleotide Changes in the Genomic SA1D2prox Region during the Viral Adaptation Process

Viruses. 2021 Oct 15;13(10):2079. doi: 10.3390/v13102079.

Abstract

HIV-1 Vif plays an essential role in viral replication by antagonizing anti-viral cellular restriction factors, a family of APOBEC3 proteins. We have previously shown that naturally-occurring single-nucleotide mutations in the SA1D2prox region, which surrounds the splicing acceptor 1 and splicing donor 2 sites of the HIV-1 genome, dramatically alter the Vif expression level, resulting in variants with low or excessive Vif expression. In this study, we investigated how these HIV-1 variants with poor replication ability adapt and evolve under the pressure of APOBEC3 proteins. Adapted clones obtained through adaptation experiments exhibited an altered replication ability and Vif expression level compared to each parental clone. While various mutations were present throughout the viral genome, all replication-competent adapted clones with altered Vif expression levels were found to bear them within SA1D2prox, without exception. Indeed, the mutations identified within SA1D2prox were responsible for changes in the Vif expression levels and altered the splicing pattern. Moreover, for samples collected from HIV-1-infected patients, we showed that the nucleotide sequences of SA1D2prox can be chronologically changed and concomitantly affect the Vif expression levels. Taken together, these results demonstrated the importance of the SA1D2prox nucleotide sequence for modulating the Vif expression level during HIV-1 replication and adaptation.

Keywords: HIV-1; SA1D2prox; Vif expression; adaptation; nucleotide sequence; splicing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • APOBEC Deaminases / metabolism
  • Adaptation, Physiological / genetics
  • Anti-Retroviral Agents / therapeutic use
  • Base Sequence / genetics
  • CD4-Positive T-Lymphocytes / metabolism
  • CD4-Positive T-Lymphocytes / virology
  • DNA, Viral / genetics
  • Gene Expression / genetics
  • Gene Expression Regulation, Viral / genetics
  • Genome, Viral / genetics
  • Genomics / methods
  • HEK293 Cells
  • HIV Infections / genetics*
  • HIV Infections / virology
  • HIV-1 / genetics
  • HIV-1 / pathogenicity
  • Humans
  • RNA Splice Sites / genetics*
  • RNA, Viral / genetics
  • Virus Replication / drug effects
  • Virus Replication / genetics
  • Virus Replication / physiology
  • vif Gene Products, Human Immunodeficiency Virus / genetics*
  • vif Gene Products, Human Immunodeficiency Virus / metabolism

Substances

  • Anti-Retroviral Agents
  • DNA, Viral
  • RNA Splice Sites
  • RNA, Viral
  • vif Gene Products, Human Immunodeficiency Virus
  • vif protein, Human immunodeficiency virus 1
  • APOBEC Deaminases
  • APOBEC3 proteins, human